Your browser doesn't support javascript.
loading
Insights into the cellular pharmacological properties of the BET-inhibitor OTX015/MK-8628 (birabresib), alone and in combination, in leukemia models.
Astorgues-Xerri, Lucile; Vázquez, Ramiro; Odore, Elodie; Rezai, Keyvan; Kahatt, Carmen; Mackenzie, Sarah; Bekradda, Mohamed; Coudé, Marie-Magdelaine; Dombret, Herve; Gardin, Claude; Lokiec, Francois; Raymond, Eric; Noel, Kay; Cvitkovic, Esteban; Herait, Patrice; Bertoni, Francesco; Riveiro, María E.
Afiliación
  • Astorgues-Xerri L; Oncology Therapeutic Development, Clichy, France.
  • Vázquez R; Institute of Oncology Research, Università della Svizzera Italiana, Bellinzona, Switzerland.
  • Odore E; RadioPharmacology Department, Curie Institute-Rene Huguenin Hospital, Saint Cloud, France.
  • Rezai K; RadioPharmacology Department, Curie Institute-Rene Huguenin Hospital, Saint Cloud, France.
  • Kahatt C; Oncology Therapeutic Development, Clichy, France.
  • Mackenzie S; Oncology Therapeutic Development, Clichy, France.
  • Bekradda M; Oncology Therapeutic Development, Clichy, France.
  • Coudé MM; Laboratoire de Transfert des Leucémies, Université Paris Diderot, Paris, France.
  • Dombret H; Laboratoire de Transfert des Leucémies, Université Paris Diderot, Paris, France.
  • Gardin C; Laboratoire de Transfert des Leucémies, Université Paris Diderot, Paris, France.
  • Lokiec F; RadioPharmacology Department, Curie Institute-Rene Huguenin Hospital, Saint Cloud, France.
  • Raymond E; Medical Oncology Department, CHUV, Lausanne, Switzerland.
  • Noel K; Oncoethix SA, Lucerne, Switzerland.
  • Cvitkovic E; Oncoethix SA, Lucerne, Switzerland.
  • Herait P; Oncoethix SA, Lucerne, Switzerland.
  • Bertoni F; Institute of Oncology Research, Università della Svizzera Italiana, Bellinzona, Switzerland.
  • Riveiro ME; Oncology Therapeutic Development, Clichy, France.
Leuk Lymphoma ; 60(12): 3067-3070, 2019 12.
Article en En | MEDLINE | ID: mdl-31204545

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Proteínas / Compuestos Heterocíclicos con 3 Anillos / Acetanilidas / Antineoplásicos Límite: Animals / Humans Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Proteínas / Compuestos Heterocíclicos con 3 Anillos / Acetanilidas / Antineoplásicos Límite: Animals / Humans Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Francia